237 related articles for article (PubMed ID: 28056971)
1. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.
Wu CC; Fang CY; Cheng YJ; Hsu HY; Chou SP; Huang SY; Tsai CH; Chen JY
J Biomed Sci; 2017 Jan; 24(1):2. PubMed ID: 28056971
[TBL] [Abstract][Full Text] [Related]
2. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
[TBL] [Abstract][Full Text] [Related]
4. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
[TBL] [Abstract][Full Text] [Related]
5. The Dietary Flavonol Kaempferol Inhibits Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells.
Wu CC; Lee TY; Cheng YJ; Cho DY; Chen JY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500249
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference.
Chang Y; Chang SS; Lee HH; Doong SL; Takada K; Tsai CH
J Gen Virol; 2004 Jun; 85(Pt 6):1371-1379. PubMed ID: 15166418
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
Wang M; Wu W; Zhang Y; Yao G; Gu B
Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
[TBL] [Abstract][Full Text] [Related]
10. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
11. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.
Choi SJ; Ryu E; Lee S; Huh S; Shin YS; Kang BW; Kim JG; Cho H; Kang H
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875759
[No Abstract] [Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
Tung CP; Chang FR; Wu YC; Chuang DW; Hunyadi A; Liu ST
J Gen Virol; 2011 Aug; 92(Pt 8):1760-1768. PubMed ID: 21490247
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.
Li H; Liu S; Hu J; Luo X; Li N; M Bode A; Cao Y
Int J Biol Sci; 2016; 12(11):1309-1318. PubMed ID: 27877083
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.
Wang P; Rennekamp AJ; Yuan Y; Lieberman PM
J Virol; 2009 Aug; 83(16):8090-8. PubMed ID: 19494003
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide Inhibits Epstein-Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins.
Malat P; Ekalaksananan T; Heawchaiyaphum C; Suebsasana S; Roytrakul S; Yingchutrakul Y; Pientong C
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889536
[TBL] [Abstract][Full Text] [Related]
18. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus.
Xu S; Zhang S; Wang X; Gao Y; Qin X; Wu K
Indian J Exp Biol; 2012 Oct; 50(10):708-13. PubMed ID: 23214264
[TBL] [Abstract][Full Text] [Related]
20. Interplay between PKCĪ“ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.
Tsai PF; Lin SJ; Weng PL; Tsai SC; Lin JH; Chou YC; Tsai CH
J Virol; 2011 Mar; 85(5):2373-85. PubMed ID: 21159880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
